New study tracks bleeding risks and Pill-Taking habits in heart patients
NCT ID NCT07458191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 800 adults with nonvalvular atrial fibrillation (a type of irregular heartbeat) who are starting the blood thinner apixaban for the first time. Researchers will track how often serious or minor bleeding occurs and how well patients stick to their medication schedule over six months. The goal is to better understand the real-world safety and adherence to this common treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONVALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic for diseases of the heart, blood vessels and rheumatism
RECRUITINGSarajevo, 71000, Bosnia and Herzegovina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.